INS and metabolic syndrome: The skeletal muscle accounts for 40-50% of the body weight and mediates 75% of insulin-stimulated glucose uptake, and is therefore one of the main potential targets for the treatment of metabolic syndrome, diabetes, and many other disorders [2-4].